241 related articles for article (PubMed ID: 35167663)
21. Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy.
Haland TF; Almaas VM; Hasselberg NE; Saberniak J; Leren IS; Hopp E; Edvardsen T; Haugaa KH
Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):613-21. PubMed ID: 26873460
[TBL] [Abstract][Full Text] [Related]
22. Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.
Swoboda PP; McDiarmid AK; Erhayiem B; Law GR; Garg P; Broadbent DA; Ripley DP; Musa TA; Dobson LE; Foley JR; Fent GJ; Page SP; Greenwood JP; Plein S
J Cardiovasc Magn Reson; 2017 Feb; 19(1):16. PubMed ID: 28215181
[TBL] [Abstract][Full Text] [Related]
23. Ventricular late potentials and myocardial fibrosis in hypertrophic cardiomyopathy.
Matsuki A; Kawasaki T; Kawamata H; Sakai C; Harimoto K; Kamitani T; Yamano M; Matoba S
J Electrocardiol; 2020; 58():87-91. PubMed ID: 31790854
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular magnetic resonance-derived myocardial strain in asymptomatic heart transplanted patients and its correlation with late gadolinium enhancement.
Shen X; Yuan Y; Yang M; Wang J; Sun W; Xie M; Zhang L; Zhou X; Liang B
Eur Radiol; 2020 Aug; 30(8):4337-4346. PubMed ID: 32232791
[TBL] [Abstract][Full Text] [Related]
25. Myocardial mechanical remodeling after septal myectomy for severe obstructive hypertrophic cardiomyopathy.
Moravsky G; Bruchal-Garbicz B; Jamorski M; Ralph-Edwards A; Gruner C; Williams L; Woo A; Yang H; Laczay B; Rakowski H; Carasso S
J Am Soc Echocardiogr; 2013 Aug; 26(8):893-900. PubMed ID: 23800507
[TBL] [Abstract][Full Text] [Related]
26. Reverse remodeling of left atrium assessed by cardiovascular magnetic resonance feature tracking in hypertrophic obstructive cardiomyopathy after septal myectomy.
Yang S; Chen X; Zhao K; Yu S; Dong W; Wang J; Yang K; Yang Q; Ma X; Dong Z; Liu L; Song Y; Lu M; Wang S; Zhao S
J Cardiovasc Magn Reson; 2023 Feb; 25(1):13. PubMed ID: 36775820
[TBL] [Abstract][Full Text] [Related]
27. Myocardial fibrosis evaluated by diffusion-weighted imaging and its relationship to 3D contractile function in patients with hypertrophic cardiomyopathy.
Wu R; An DA; Shi RY; Chen BH; Jiang M; Bacyinski A; Han TT; Hu J; Xu JR; Wu LM
J Magn Reson Imaging; 2018 Oct; 48(4):1139-1146. PubMed ID: 29601139
[TBL] [Abstract][Full Text] [Related]
28. CMR feature tracking in patients with dilated cardiomyopathy: patterns of myocardial strain and focal fibrosis.
Chevalier C; Kremer K; Cavus E; Schneider J; Jahnke C; Schön G; Radunski UK; Tahir E; Adam G; Lund G; Kirchhof P; Blankenberg S; Muellerleile K
Open Heart; 2022 Dec; 9(2):. PubMed ID: 36522125
[TBL] [Abstract][Full Text] [Related]
29. Increased amount of interstitial fibrosis predicts ventricular arrhythmias, and is associated with reduced myocardial septal function in patients with obstructive hypertrophic cardiomyopathy.
Almaas VM; Haugaa KH; Strøm EH; Scott H; Dahl CP; Leren TP; Geiran OR; Endresen K; Edvardsen T; Aakhus S; Amlie JP
Europace; 2013 Sep; 15(9):1319-27. PubMed ID: 23426552
[TBL] [Abstract][Full Text] [Related]
30. Myocardial Fibrosis in Hypertrophic Cardiomyopathy: Volumetric Assessment of Late Enhancement Provided by Cardiac Computed Tomography.
Langer C; Schaefer P; Lutz M; Eden M; Hohnhorst M; Harders H; Faber L; Jansen O; Both M; Frey N
J Comput Assist Tomogr; 2015; 39(5):797-803. PubMed ID: 26125299
[TBL] [Abstract][Full Text] [Related]
31. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy.
Buss SJ; Breuninger K; Lehrke S; Voss A; Galuschky C; Lossnitzer D; Andre F; Ehlermann P; Franke J; Taeger T; Frankenstein L; Steen H; Meder B; Giannitsis E; Katus HA; Korosoglou G
Eur Heart J Cardiovasc Imaging; 2015 Mar; 16(3):307-15. PubMed ID: 25246506
[TBL] [Abstract][Full Text] [Related]
32. Additional prognostic values of strain and strain rate over late gadolinium enhancement in hypertrophic cardiomyopathy patients.
Qin L; Zhu S; Liu P; Zhu L; Chen C; Gu S; Yang W; Zhou M; Yan F
Int J Cardiol; 2023 Jan; 370():427-434. PubMed ID: 36332750
[TBL] [Abstract][Full Text] [Related]
33. Microvascular Rarefaction and Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy.
Tian H; Yang C; Song Y; Wang H; Yuan J; Cui J; Liu S; Hu F; Yang W; Jiang X; Qiao S
Cardiology; 2018; 141(4):202-211. PubMed ID: 30820009
[TBL] [Abstract][Full Text] [Related]
34. Predicting Left Ventricular Myocardial Fibrosis in Patients with Hypertrophic Cardiomyopathy by Speckle Tracking Automated Functional Imaging.
Hu X; Bao Y; Zhu Y; Zheng K; Zhang J; Zhou W; Deng Y; Liu Y
Ultrasound Med Biol; 2023 May; 49(5):1309-1317. PubMed ID: 36863952
[TBL] [Abstract][Full Text] [Related]
35. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
McLELLAN AJ; Ellims AH; Prabhu S; Voskoboinik A; Iles LM; Hare JL; Kaye DM; Macciocca I; Mariani JA; Kalman JM; Taylor AJ; Kistler PM
J Cardiovasc Electrophysiol; 2016 May; 27(5):571-80. PubMed ID: 26840595
[TBL] [Abstract][Full Text] [Related]
36. Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function.
Mentias A; Raeisi-Giglou P; Smedira NG; Feng K; Sato K; Wazni O; Kanj M; Flamm SD; Thamilarasan M; Popovic ZB; Lever HM; Desai MY
J Am Coll Cardiol; 2018 Aug; 72(8):857-870. PubMed ID: 30115224
[TBL] [Abstract][Full Text] [Related]
37. The Combination of Feature Tracking and Late Gadolinium Enhancement for Identification Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease.
Liu S; Li Y; Zhao Y; Wang X; Wu Z; Gu X; Xu B; Li Y; Tian J; Cui J; Wang G; Yu B
Front Cardiovasc Med; 2022; 9():865615. PubMed ID: 35647085
[TBL] [Abstract][Full Text] [Related]
38. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
[TBL] [Abstract][Full Text] [Related]
39. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
[TBL] [Abstract][Full Text] [Related]
40. Correlation of electrocardiographic changes and myocardial fibrosis in patients with hypertrophic cardiomyopathy detected by cardiac magnetic resonance imaging.
Song BG; Yang HS; Hwang HK; Kang GH; Park YH; Chun WJ; Oh JH
Clin Cardiol; 2013 Jan; 36(1):31-5. PubMed ID: 23070984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
